Bellevue Asset Management (Switzerland)’s Kite Pharma, Inc. KITE Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$863K	Sell	14,000 -105,500	-88%	-$7.43M	0.13%	105
2015 Q3	$6.65M	Sell	119,500 -55,500	-32%	-$3.49M	1.09%	30
2015 Q2	$10.7M	Buy	175,000 +7,000	+4%	+$399K	1.48%	19
2015 Q1	$9.69M	Buy	+168,000	New	+$11.3M	1.35%	23

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s KITE Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) reduced its Kite Pharma, Inc. (KITE) stake by 88% in Q4 2015, selling an estimated $7.43M and leaving 14,000 shares worth $863K. The position accounts for 0.13% of the portfolio, ranked #105.

Bellevue Asset Management (Switzerland) first reported a position in KITE in Q1 2015 and has held it in 4 quarters since. The position peaked at $10.7M in Q2 2015. 187 funds tracked by Wall St. Rank hold KITE as of Q4 2015.

Bellevue Asset Management (Switzerland) held 14,000 shares of Kite Pharma, Inc. worth $863K as of Q4 2015.
Bellevue Asset Management (Switzerland) sold 105,500 Kite Pharma, Inc. shares in Q4 2015, an estimated $7.43M.
Kite Pharma, Inc. made up 0.13% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #105 holding.
Bellevue Asset Management (Switzerland) first reported a position in Kite Pharma, Inc. in Q1 2015 and has held it in 4 quarters since.
Bellevue Asset Management (Switzerland)'s Kite Pharma, Inc. position peaked at $10.7M in Q2 2015.
187 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.